The molecular biology of retinoblastoma

References

• Char DH. Clinical Ocular Oncology, 2nd edition. Philadelphia: Lippincott-Raven, 1997.
   Google Scholar
• Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JJ. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85:1121–1128.
   PubMed Web of Science ®Google Scholar
• Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820–823.
   PubMed Web of Science ®Google Scholar
• Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987;235:1394–1399.
   PubMed Web of Science ®Google Scholar
• Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323: 643–646.
   Google Scholar
• Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WE Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987;236:1657–1661.
   PubMed Web of Science ®Google Scholar
• Harbour JVV, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988;241:353–357.
   Google Scholar
• Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988;241:218–221.
   PubMed Web of Science ®Google Scholar
• Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305: 779–784.
   Google Scholar
• Harbour JVV. Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening. Ophthalmology 1998;105:1442–1447.
   Google Scholar
• Otterson GA, Chen WD, Coxon AB, Khleif SN, Kaye FJ. Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. Proc Natl Acad Sci USA 1997;94:12036-1204o.
   Google Scholar
• Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987;329:642–645.
   PubMed Web of Science ®Google Scholar
• DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989;58: 1085–1095.
   Google Scholar
• Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC. Exit from GI and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNE Cell 2000; I 0 E 79–89.
   Google Scholar
• Strobeck MW, Fribourg AF, Puga A, Knudsen ES. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene 200019:1857-1867.
   PubMed Web of Science ®Google Scholar
• Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol Cell Biol 2000;20: 4210–4223.
   Google Scholar
• Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 1998;9:585–593.
   PubMedGoogle Scholar
• Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991;65: 1053–1061.
   Google Scholar
• Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 1995;375:812–815.
   PubMed Web of Science ®Google Scholar
• Zhang HS, Postigo AA, Dean DC. Active transcriptional repression by the Rb-E2F complex mediates GI arrest triggered by pi6INK4a, TGFI3, and contact inhibition. Cell 1999;97: 53–61.
   Google Scholar
• Luo RX, Postigo AA, Dean DC. Rb interacts with histone deacetylase to repress transcription. Cell 1998;92: 463–473.
   Google Scholar
• Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000;2: E65–67.
   PubMed Web of Science ®Google Scholar
• Harbour JW, Luo RX, Dei Sante A, Postigo AA, Dean DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through GI. Cell 1999; 98:859–869.
   Google Scholar
• Shackney SE, Shankey TV. Cell cycle models for molecular biology and molecular oncology: exploring new dimensions. Cytometry 1999;35:97–I 16.
   Google Scholar
• Sherr CJ. Cancer cell cycles. Science 1996;274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998;18:753–761.
   PubMed Web of Science ®Google Scholar
• Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366: 704–707.
   Google Scholar
• Brantley MA Jr, Harbour JW. Inactivation of Rb in uveal melanoma by phosphorylation of sites in the C-terminal region. Cancer Res 2000;60:4320–4323.
   PubMed Web of Science ®Google Scholar
• Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992;359:295–300.
   PubMed Web of Science ®Google Scholar
• Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992;359:288–294.
   PubMed Web of Science ®Google Scholar
• Clarke AR, Maandag ER, Van Roon M, Van der Lugt NM, Van der Valk M, Hooper ML, Berns A, Te Riele H. Requirement for a functional Rb- gene in murine development. Nature 1992;359:328–330.
   Google Scholar
• Windle JJ, Albert DM, O'Brien JM, Marcus DM, Disteche CM, Bernards R, Mellon PL. Retinoblastoma in transgenic mice. Nature 1990;343: 665–669.
   Google Scholar
• Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM, Windle JJ. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-I6 E7 gene in the presence or absence of p53. Genes Dev 1994;8:1300–1310.
   PubMed Web of Science ®Google Scholar
• Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 1999;59: 1731s-1735s.
   Google Scholar
• Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994;371:72–74.
   PubMed Web of Science ®Google Scholar
• Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 1998;95: 5–8.
   PubMed Web of Science ®Google Scholar
• Symonds H, Kra11 L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994; 78:703–71L
   Google Scholar
• Maandag EC, Van der Valk M, Vlaar M, Feltkamp C, O'Brien J, Van Roon M, Van der Lugt N, Berns A, Te Riele H. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. Eur Mol Biol Organ (EMBO) J 1994;13:4260–4268.
   Google Scholar
• Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. Eur Mol Biol Organ (EMBO) J 1994;13:4251–4259.
   Google Scholar
• Lipinski MM, Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene 1999;18:7873–7882.
   PubMed Web of Science ®Google Scholar